Could Japan's antibiotic incentive model succeed in the U.S.?

In Japan, the government incentivizes doctors to avoid unnecessary antibiotic prescriptions, a model that has prompted discussions about its potential in the U.S. Research shows that caregivers often request antibiotics for children, leading to pressure on doctors to prescribe them. Dr. Conor Blanco believes a similar program could work in the U.S., although some doctors worry it may reinforce negative perceptions about financial motivations in healthcare. Urgent care centers are significant contributors to antibiotic overprescription, highlighting the need for better education and targeted interventions to reduce unnecessary prescriptions.

Could Japan's antibiotic incentive model succeed in the U.S.?
1 source
Published Aug 11, 2026

Topic overview

Briefly

  • Japan has implemented an incentive program to reduce unnecessary antibiotic prescriptions.
  • In the U.S., social pressure from caregivers often leads to overprescription of antibiotics.
  • Experts suggest that adapting Japan's model could help address antibiotic overuse in the U.S.

What happened

In Japan, the government has implemented an incentive program aimed at reducing unnecessary antibiotic prescriptions by encouraging doctors to avoid prescribing them for certain ailments. This approach has sparked discussions about its potential applicability in the United States, where overprescription of antibiotics remains a significant issue. Research indicates that caregivers often request antibiotics for their children, leading to social pressure on doctors to comply, even when the prescriptions are not warranted. Dr. Conor Blanco, a pediatric ENT from New Jersey, expressed optimism that a similar program could be effective in the U.S., suggesting that it might help alleviate the pressure on physicians to prescribe antibiotics unnecessarily.

However, not all medical professionals share this enthusiasm. Some doctors are concerned that implementing such an incentive could exacerbate existing perceptions that U.S. doctors are overly motivated by financial gain. The complexity of the U.S. healthcare system, with its diverse mix of insurance providers and reimbursement models, poses additional challenges to the uniform implementation of a Japanese-style incentive program. Currently, various commercial insurers and private groups managing Medicare and Medicaid plans utilize metrics to track antibiotic usage for conditions that are often viral, such as upper respiratory infections and bronchitis.

While pediatrics clinics are not the primary source of antibiotic overprescription, urgent care centers have been identified as significant contributors. A study analyzing millions of urgent care visits found that antibiotics were prescribed in 15% of bronchitis cases, where they are rarely needed. Interestingly, a majority of parents expressed a willingness to learn more about antibiotics, even when the treatment plan did not align with their initial expectations. This indicates an opportunity for healthcare providers to educate caregivers about the appropriate use of antibiotics and the distinction between viral and bacterial infections.

Furthermore, data suggests that physician assistants (PAs) and nurse practitioners (NPs) are more likely to prescribe antibiotics than physicians, particularly in pediatric cases. This trend highlights the need for targeted interventions aimed at these providers to reduce unnecessary prescriptions. Clinical documentation practices could be enhanced to ensure that healthcare providers communicate the rationale for denying antibiotic prescriptions to patients effectively. By improving patient education and understanding of antibiotics, the pressure on doctors to prescribe them could be significantly reduced, ultimately leading to better health outcomes and a decrease in antibiotic resistance.

Comprehensive report

Full story,
in detail.

Trace the developments that led here, see how the story evolved, and understand the forces and wider context surrounding it.

Entities

How Mestios works We aggregate coverage, extract key information, and use AI to summarize and compare perspectives. Learn more

Updated Aug 11, 2026

AI-generated summary. Please verify important information from original sources.